Origin Asset Management LLP Vertex Pharmaceuticals Inc Transaction History

Origin Asset Management LLP

  • $363 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$207.02 - $241.31 $724,570 - $844,585
-3,500 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $153,390 - $181,860
600 Added 20.69%
3,500 $952,000
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $653,892 - $857,820
2,900 New
2,900 $842,000

Others Institutions Holding VRTX

# of Institutions
1,625
Shares Held
222M
Call Options Held
1.35M
Put Options Held
1.49M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Origin Asset Management LLP Portfolio

Follow Origin Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Origin Asset Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email